Clinical trial
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
NCT02661958 is registered in ClinicalTrials.gov with Sol-Gel Technologies, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
- Lead sponsor
- Sol-Gel Technologies, Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2016
- Completion date
- October 31, 2017
- Enrollment
- 726 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.